Astec Lifesciences Ltd's Board Meeting on 29th October 2025 approved unaudited financial results for the quarter and half-year ended 30th September 2025, noting the Statutory Auditors' unmodified review reports. Financial figures include a subsidiary's total assets of Rs. 155.34 lakhs and net profit of Rs. 2.91 lakhs for the quarter.